Abstract Poor dyspnoea perception in asthmatic patients seems to be associated with increased risk of asthma exacerbation.We have studied the relationship between baseline dyspnoea perception and in£ammatory markers in sputumin eight patients with mild asthma and in13 patients with moderate to severe asthma.The perception of dyspnoea was scored on the Borg scale. Eosinophilic cationic protein (ECP) was measured by £uoroimmunoassay and by an interleukin (IL)-5 sandwich ELlSA. The baseline Borg score was signi¢cantly higher in patients with severe asthma than in patients with mild to moderate asthma (4?170?29 vs. 2?2870?28, Po0?05).The proportion of eosinophil and ECPlevels in the sputum were signi¢cantly higher in patients with moderate to severe asthma. IL-5 in sputum was signi¢cantly increased in moderate to severe asthmatic patients compared to mild asthmatic patients. A signi¢cant relationship was found between the baseline perception score and FEV 1 /FVC (r = À0?53, Po0?01), sputum eosinophils (r = 0?70, Po0?01) and sputum ECP (r = 0?62, Po0?01).These ¢ndings suggestthatthe baseline perception score is related to in£ammatory markers in sputum, and that the perception of dyspnoea as well as airway in£ammatory markers may be considered to evaluate asthma severity. r 2002
INTRODUCTION
Bronchial asthma is de¢ned as a chronic in£ammatory disorder of the airways in which many cells and cellular elements play a role. In particular, mast cells, eosinophils, T lymphocytes, neutrophils and epithelial cells have been implicated. In susceptible individuals, this in£ammation causes recurrent episodes of wheezing, breathlessness, chest tightness and cough, particularly at night and in the early morning (1) .
Patients with severe asthma seem to have a reduced ability to perceive air£ow obstruction. Perception of dyspnoea during breathing through a series of tubes with increasing resistance was signi¢cantly decreased in patients with a history of near-fatal asthma attacks, as compared with patients who had asthma of similar severity but no history of such attacks (2, 3) . The authors reported that inhalation of a short-acting b 2 -agonist decreased dyspnoea, but increased the perception of dyspnoea induced by a resistive load in patients with asthma (4) . Markers of airway in£ammation in induced sputum were correlated with clinical and physiological variables (5, 6) .
In the present study we hypothesized that airway in£ammation in patients with asthma may in£uence perception of dyspnoea. The aim of this study was therefore to evaluate the relationship between the perception of dyspnoea and in£ammatory markers in sputum.
METHODS Subjects
Twenty-one patients with asthma were enrolled for this study (Table1).The diagnoses of asthma were established in the patients by their symptoms of recurrent episodic wheezing, cough and/or dyspnoea, accompanied either by methacholine airway hyper-responsiveness or by a signi¢cant improvement of forced expiratory volume in 1sec (FEV 1 ) (15%) following anti-asthma therapy. The severity of asthma (8) was classi¢ed according to current symptoms (cough, wheeze, dyspnoea), prescribed asthma medication and results of methacholine provocation test. Sixteen patients were hyper-responsive to inhaled methacholine as shown by a provocative concentration to cause a 20% fall in FEV 1 (PC 20 ). The patients with severe asthma consisted of six patients who had two or more exacerbations during the preceding year requiring treatment with oral corticosteroids despite high-dose inhaled corticosteroid therapy (budesonide 800 mg twice daily or £uticasone propionate 500 mg twice daily). The patients with moderate asthma consisted of seven patients who had inhaled high dose corticosteroid therapy (budesonide 800 mg twice daily or £uticasone propionate 250 mg twice daily). The patients were recruited from our outpatient allergy department.Most of them had visited our hospital for many years, mostly on a 3^6 month basis and during exacerbations. Inhaled corticosteroids were routinely tapered to lowest possible doses. All subjects had inhaled short-acting b 2 -agonists on demand as rescue medication. The subjects ware studied prior to corticosteroid treatment during an exacerbation. No subject had respiratory infection for 4 weeks prior to the study. All subjects were informed and gave their consent before starting the study. The ethics committee of our hospital approved the study protocol.
Scoring of dyspnoea
The scoring of dyspnoea perception on admission was measured using a modi¢ed Borg scale (9) . This is a linear scale of the numbers ranking the magnitude of di⁄culty in breathing, ranging from 0 (none) to 10 (maximal) ( Table 1) .
Bronchial hyper-responsiveness
Methacholine challenge tests were carried out by a modi¢ed method described by Chai et al. methacholine were prepared by dilution with bu¡ered saline. A Micro-dosimeter (S&M Instrument Co, Doylestown, PA, U.S.A.) was used to deliver the aerosol generated by a DeVilbiss 646 nebulizer. Subjects inhaled ¢ve breaths of increasing concentrations of methacholine until FEV 1 fell by more than 20% of its basal value or the highest concentration was reached. The higher value of these FEV 1 at (30 or 90 and 180 sec after each inhalation) was adopted for analysis.
Sputum induction and processing
Sputum was induced only when it could not be produced spontaneously. The sputum induction was performed as a modi¢cation of the method described by Fahy et al. (11) All subjects were premedicated with two pu¡s of inhaled salbutamol (200 mg). Subjects inhaled 3% hypertonic saline solution aerosols generated by a ultrasonic nebulizer (NE-U03, OMRON Co., Tokyo, Japan) with maximum output of 0?15^0?3 mlmin À1 and mass median aerodynamic diameter of 4?5 mm. Hypertonic saline was inhaled for 25^30 min according to the severity of asthma until adequate volume of sputum was expectorated. They were instructed to cough the sputum into a sterile plastic container. The volumes of samples and duration of sputum induction were recorded. FEV 1 was measured before, during and after induction of sputum. Sputum induction was stopped in subject with a fall of the FEV 1 !15%.
Sputum was selected from saliva and processed within 2 h.The method of sputum examination described by Popov et al. (12) was modi¢ed. Sputum was treated by adding equal volumes of 0?1% dithiothreitol (Sputalysin 10%; Gibco BRL, U.S.A.) followed by equal volumes of Dulbecco's phosphate-bu¡ered saline (D-PBS). The sample was then mixed gently and placed in a shaking water bath at 371C for15 min to ensure complete homogenization.The sample was removed from the water-bath periodically for further brief gentle mixing. The suspension was ¢l-tered through a gauze (1mm pore size), the ¢ltrate was centrifuged at 1500 rpm for 10 min and the supernatant was aspirated and stored in Eppendorf tubes at À701C for later assay. The cell pellet was resuspended in D-PBS, 1000 ml and total non-squamous cells were counted in a modi¢ed Neubauer haemocytometer. The cell suspension was adjusted to 0?5 Â10 5 ml À1 and then 50 ml of cell suspension was placed into cups of Sakura cytocentrifuge (Model CF-127, Tokyo, Japan). Two coded cytospins were prepared at 600 rpm for 5 min, air-dried and stained by Di¡-Quick (Kookje Scienti¢c Products, Japan) stain. Cell di¡erentials of 400 non-squamous cells were performed in Di¡-Quick stain slides by two investigators who did not know the subject's history, and results were expressed as a percentage of the total non-squamous cell count.
ECP and IL-5 measurement
The concentration of ECP in 400 ml in the supernatant of induced sputum was determined using £uoroimmunoas- 
Blood sampling
Venous blood was collected tubes containg 5?0 ml ethylenediaminetetraacetic acid (K3 Vacutainer BD, Rutherfold, NJ, U.S.A.) before sputum induction. Di¡erentiaI white blood cell count was obtained with use of a Coulter STKS instrument (Coulter Corp., Hialeah, FL, U.S.A.)
StatisticaI analysis
All data were analysed using the SPSS version 7?5 for Windows. Data are expressed as mean7SEM. We used the Mann^Whitney U-test for unpaired data to perform statistical analysis. Spearman's correlations with nonnormal distributions were used to assess relationships between variables. A P-value of o0?05 was considered signi¢cant.
RESULTS
The characteristics of the subjects including demographics, asthma severity are shown in Table 2 . The baseline Borg score was signi¢cantly higher in patients with severe asthma than patients with mild to moderate asthma (2?2870?28 vs. 4?170?29, Po0?05; Fig. 1 ). A signi¢cant relationship was found between the baseline perception score and FEV 1 /FVC (r = 0?53, Po0?01; Fig. 2 ) as well as between baseline perception score and both sputum eosinophil percentage (r = 0?70, Po0?01; Fig. 3 ) and sputum ECP (r = 0?62, Po0?01). However, no relationship was found between baseline perception score and serum eosinophils or serum ECP.
DISCUSSION
This study has demonstrated that the dyspnoea perception score is related to in£ammatory markers in sputum, which suggests that the perception of dyspnoea as well as airway in£ammatory markers may be considered to evaluate the clinical severity of asthma.
Poor perception in asthma may lead to a delay in starting appropriate asthma treatment, which is probably one of the key factors contributing to death from asthma (14) . Recent studies have reported that blunted perception of acutely induced bronchoconstriction (15) , and less severe breath lessness induced by inspiratory loads, was detected in near fatal attack patients (16) . We have also reported that inhalation of a short-acting b 2 -agonist treatment decreases dyspnoea, but increases perception of dyspnoea induced by a resistive load in patients with asthma (4).
The severity of dyspnoea is shown to be greater in response to hypertonic saline as compared with methacholine at the same reduction of FEV 1 (17) , which might be explained by di¡erences in perception due to in£am-matory activity within the airways (17, 18 ). An association between perception of breathlessness and airway in£ammation has previously been reported, as measured by eosinophilic in¢ltration and epithelial shedding in bronchial biopsies from patients with asthma (19) . However, there have been no published data comparing baseline perception score with airway in£ammation markers in sputum. In the present study, the baseline Borg score was signi¢cantly higher in patients with severe asthma compared with patients with mild to moderate asthma. According to asthma severity, the proportion of eosinophil and ECP levels in sputum were signi¢cantly increased in patients with moderate to severe asthma than in those of mild asthma. IL-5 in sputum was also signi¢cantly increased in moderate to severe asthmatic patients compared to mild asthmatic patients. These results support the idea that awareness of perception of dyspnoea is correlated with sputum in£ammatory markers, and that increased eosinophilic in£ammation is associated with more pronounced dyspnoea score. Further studies are needed to evaluate the relationship between perception score and in£ammatory marker changes after Iong-term anti-in£ammatory control medication.
in't Veen et al. (20) reported that increased sputum eosinophilia is an indicator of clinical instability, and that eosinophilic airways in£ammation might a¡ect dyspnoea perception in severe asthma. In this study the proportion of eosinophil in sputum was increased in patients with severe asthma, suggesting that sputum eosinophils might be a valuable marker of clinical severity in asthma. Roisman et al. (19) reported that perception of bronchoconstriction in asthmatic patients is related to eosinophilic in£ammation and to epithelial damage in airways, and that corticosteroid treatment is associated with improved perception of bronchoconstriction induced by bradykinin. The sensation of dyspnoea was also found to be signi¢cantly related to the FEV 1 and the speci¢c inspiratory resistance in the asthmatics (21) . This study shows a signi¢cant relationship between the baseline perception score and FEV 1 /FVC, sputum eosinophils and sputum ECP, which is in agreement with the results of Roisman et al. (19) . This study shows that perception of breathlessness associated with bronchoconstriction may be in£uenced by the degree of eosinophilic in¢ltration, which is related to the clinical severity of asthma.
Low baseline FEV 1 and high bronchial responsiveness are associated with a low degree of 'perceptiveness' for bronchoconstriction, suggesting that patients with a more severe degree of asthma either show adaptation of 'perceptiveness' for airway obstruction or that low perceptiveness leads to more severe asthma. Although asthmatic patients poorly perceive dyspnoea, dyspnoea perception is related to in£ammatory markers (22) . Therefore, we suggest that the perception of dyspnoea may be considered in evaluating of clinical severity of asthma.
The degree of in£ammation in airways as well as asthma severity depends on the anti-in£ammmatory load. Anti-leukotrienes and inhaled corticosteroid might a¡ect the perception di¡erently depending on di¡erent targeting and mechanism of action, and possibly side-effects. In this study the e¡ect of sputum on anti-in£amma-tory therapy was small because sputum induction was studied before corticosteroid therapy.
In conclusion, we found that the baseline perception score is related to in£ammatory markers in sputum, suggesting that the perception of dyspnoea as well as airway in£ammatory markers may be considered to evaluate the clinical severity of asthma. 
